{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:11:10Z","timestamp":1791202270442,"version":"4.2.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/leu.2008.348","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T15:36:27Z","timestamp":1235057787000},"page":"784-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma"],"prefix":"10.1038","volume":"23","author":[{"given":"E","family":"Drakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Atsaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Leventaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Z","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"BFleu2008348_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661\u2013665.","journal-title":"Nature"},{"key":"BFleu2008348_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656\u2013660.","journal-title":"Nature"},{"key":"BFleu2008348_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cell.2006.12.007","volume":"127","author":"CP Martins","year":"2006","unstructured":"Martins CP, Brown-Swigart L, Evan GI . Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006; 127: 1323\u20131334.","journal-title":"Cell"},{"key":"BFleu2008348_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"HG Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428: 332\u2013337.","journal-title":"Nature"},{"key":"BFleu2008348_CR5","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.1158\/0008-5472.CAN-06-0419","volume":"66","author":"HG Wendel","year":"2006","unstructured":"Wendel HG, Malina A, Zhao Z, Zender L, Kogan SC, Cordon-Cardo C et al. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res 2006; 66: 7639\u20137646.","journal-title":"Cancer Res"},{"key":"BFleu2008348_CR6","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1073\/pnas.0502857102","volume":"102","author":"Z Feng","year":"2005","unstructured":"Feng Z, Zhang H, Levine AJ, Jin S . The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102: 8204\u20138209.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008348_CR7","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","volume":"23","author":"V Fernandez","year":"2005","unstructured":"Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A . Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 2005; 23: 6364\u20136369.","journal-title":"J Clin Oncol"},{"key":"BFleu2008348_CR8","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","volume":"169","author":"E Peponi","year":"2006","unstructured":"Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ . Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol 2006; 169: 2171\u20132180.","journal-title":"Am J Pathol"},{"key":"BFleu2008348_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1044-579X(02)00099-8","volume":"13","author":"D Michael","year":"2003","unstructured":"Michael D, Oren M . The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003; 13: 49\u201358.","journal-title":"Semin Cancer Biol"},{"key":"BFleu2008348_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844\u2013848.","journal-title":"Science"},{"key":"BFleu2008348_CR11","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1073\/pnas.0507493103","volume":"103","author":"C Tovar","year":"2006","unstructured":"Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci USA 2006; 103: 1888\u20131893.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008348_CR12","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1182\/blood-2005-02-0553","volume":"106","author":"K Kojima","year":"2005","unstructured":"Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, McQueen T et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 2005; 106: 3150\u20133159.","journal-title":"Blood"},{"key":"BFleu2008348_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1182\/blood-2005-12-5148","volume":"108","author":"K Kojima","year":"2006","unstructured":"Kojima K, Konopleva M, McQueen T, O'Brien S, Plunkett W, Andreeff M . Mdm2 inhibitor nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Blood 2006; 108: 993\u20131000.","journal-title":"Blood"},{"key":"BFleu2008348_CR14","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1158\/1078-0432.CCR-06-2581","volume":"13","author":"E Drakos","year":"2007","unstructured":"Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M et al. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Clin Cancer Res 2007; 13: 3380\u20133387.","journal-title":"Clin Cancer Res"},{"key":"BFleu2008348_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/sj.leu.2400555","volume":"11","author":"DM Jadayel","year":"1997","unstructured":"Jadayel DM, Lukas J, Nacheva E, Bartkova J, Stranks G, De Schouwer PJ et al. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Leukemia 1997; 11: 64\u201372.","journal-title":"Leukemia"},{"key":"BFleu2008348_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2004-06-2125","volume":"105","author":"GZ Rassidakis","year":"2005","unstructured":"Rassidakis GZ, Feretzaki M, Atwell C, Grammatikakis I, Lin Q, Lai R et al. Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma. Blood 2005; 105: 827\u2013829.","journal-title":"Blood"},{"key":"BFleu2008348_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.leukres.2005.11.013","volume":"30","author":"J Camps","year":"2006","unstructured":"Camps J, Salaverria I, Garcia MJ, Prat E, Be\u00e0 S, Pole JC et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 2006; 30: 923\u2013934.","journal-title":"Leuk Res"},{"key":"BFleu2008348_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","volume":"26","author":"R Lai","year":"2002","unstructured":"Lai R, McDonnell TJ, O\u2019Connor SL, Medeiros LJ, Oudat R, Keating M et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 2002; 26: 849\u2013855.","journal-title":"Leuk Res"},{"key":"BFleu2008348_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFleu2008348_CR20","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay N, Sonenberg N . Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926\u20131945.","journal-title":"Genes Dev"},{"key":"BFleu2008348_CR21","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 2006; 108: 1668\u20131676.","journal-title":"Blood"},{"key":"BFleu2008348_CR22","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1182\/blood-2005-11-4465","volume":"107","author":"P Secchiero","year":"2006","unstructured":"Secchiero P, Barbarotto E, Tiribelli M, Zerbinati C, di Iasio MG, Gonelli A et al. Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). Blood 2006; 107: 4122\u20134129.","journal-title":"Blood"},{"key":"BFleu2008348_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283\u2013293.","journal-title":"Mol Cell"},{"key":"BFleu2008348_CR24","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","volume":"67","author":"Z Feng","year":"2007","unstructured":"Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007; 67: 3043\u20133053.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008348","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:32:56Z","timestamp":1648729976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFleu2008348"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.348","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"12 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}